Scan to download
BTC $74,813.30 +0.24%
ETH $2,337.94 -0.58%
BNB $631.25 +1.45%
XRP $1.43 +1.96%
SOL $88.26 +3.93%
TRX $0.3267 +0.24%
DOGE $0.0982 +3.41%
ADA $0.2561 +4.30%
BCH $453.19 +2.92%
LINK $9.46 +2.40%
HYPE $43.83 -1.46%
AAVE $113.66 +7.23%
SUI $0.9935 +3.68%
XLM $0.1669 +5.38%
ZEC $341.23 -0.43%
BTC $74,813.30 +0.24%
ETH $2,337.94 -0.58%
BNB $631.25 +1.45%
XRP $1.43 +1.96%
SOL $88.26 +3.93%
TRX $0.3267 +0.24%
DOGE $0.0982 +3.41%
ADA $0.2561 +4.30%
BCH $453.19 +2.92%
LINK $9.46 +2.40%
HYPE $43.83 -1.46%
AAVE $113.66 +7.23%
SUI $0.9935 +3.68%
XLM $0.1669 +5.38%
ZEC $341.23 -0.43%

QLGN: The configuration of the cryptocurrency custody account has been completed, and the first batch of strategic asset purchases for CXC 10 will be launched this week

2025-10-13 11:51:50
Collection

ChainCatcher news, Nasdaq-listed company Qualigen Therapeutics (QLGN) announced that it has completed the establishment of infrastructure such as cash settlements in USD, bank accounts, and cryptocurrency custody accounts over the past two weeks, and will officially start purchasing its first batch of strategic assets this week, primarily investing in the top 10 cryptocurrencies by market capitalization, with a focus on "blue-chip" crypto assets including BNB, ETH, SOL, etc.

Previously, it was reported that FF has made a strategic investment of $41 million in Nasdaq-listed company QLGN, with Jia Yueting investing $4 million. QLGN will be renamed CXC 10.

app_icon
ChainCatcher Building the Web3 world with innovations.